Contact us for more information or to book your assessment visit!

Find the specialized Gondola® Partner Center nearest you and book an appointment to assess your treatment response.

I am a*
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

1.       Barbic et al 2014

2.       Galli et al 2015

3.       Stocchi et al 2015

4.       Kleiner et al 2015

5.       Quattrocchi et al 2015

6.       Galli et al 2018

7.       Pagnussat et al 2018

8.       Pinto et al 2018

9.       Kleiner et al 2018 

10.     Zamuner et al 2019

11.     Pagnussat et al 2020

outcomes

Cardiovascular Modulation

Clinical studies reported that Gondola AMPS therapy can positively affect the cardiovascular system in patients with Parkinson’s disease. 

Increase in both cardiac and vascular sympathetic modulation in upright position

Increased LF/HF and LF sap during tilt(1)

Significant decrease in BRS index

24h after stimulation, suggestive of a functional widening of baroreceptor sensitivity (1) (upright position).

Supine Arterial Blood Pressure

Supine Arterial Blood Pressure (10)

Cardiovascular Autonomic control

Cardiovascular Autonomic control (1, 10)

Arterial baroreflex sensitivity

Arterial baroreflex sensitivity (10)

1.       Barbic et al 2014

2.       Galli et al 2015

3.       Stocchi et al 2015

4.       Kleiner et al 2015

5.       Quattrocchi et al 2015

6.       Galli et al 2018

7.       Pagnussat et al 2018

8.       Pinto et al 2018

9.       Kleiner et al 2018 

10.     Zamuner et al 2019

11.     Pagnussat et al 2020

1.       Barbic et al 2014

2.       Galli et al 2015

3.       Stocchi et al 2015

4.       Kleiner et al 2015

5.       Quattrocchi et al 2015

6.       Galli et al 2018

7.       Pagnussat et al 2018

8.       Pinto et al 2018

9.       Kleiner et al 2018 

10.     Prusch et al 2018

11.     Zamuner et al 2019

12.     Pagnussat et al 2020